Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms
Clinical trial NCT00004688 · COMPLETED
Trial details
- NCT number
- NCT00004688
- Sponsor
- Emory University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1996-08-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.